Searched for
PFIZER SPOKESPERSON
Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...- Amazon says restoring damaged Middle East cloud operations to take monthsAmazon Web Services anticipates several months to restore cloud operations in Bahrain and the UAE following Iranian drone strikes in early ...
- GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technologyGlaxoSmithKline (GSK) has filed a lawsuit against Pfizer and BioNTech in Delaware federal court, alleging infringement of GSK's patents rel...
- SEC no to clinical trial waiver for Pfizer's Covid pillThe SEC asked the companies to conduct bioavailability and bioequivalence (BA/BE) studies and submit safety data at its meeting on Friday, ...
- Pfizer may offer Covid antiviral drug to India at lower price for nowPfizer has entered into advance purchase agreements with multiple countries. Sources told ET that Pfizer is yet to apply for emergency use ...
- India may have to wait longer for Pfizer, GSK's Covid drugsLast month Pfizer had announced an agreement with the UN's Medicines Patent Pool (MPP) for licensing antiviral intellectual property to MPP...
- US nod in Hand, Pfizer is looking for partners to make Covid drug in IndiaThe company has begun investing $1 billion, at risk, in the manufacture of its potential Covid-19 oral antiviral drug with the goal of maki...
- Received bid for Pfizer vaccine, says BMC; company deniesThe Municipal Corporation of Greater Mumbai said on Tuesday that it has received eight bids for the global tender floated by it for the pro...
- Discussions underway with GOI for supply of Pfizer-BioNTech COVID vaccine, says PfizerIn a statement on Monday, Pfizer spokesperson said: "Pfizer's discussions with the GOI are ongoing and we are hopeful to bring the Pfizer-B...
- Pfizer to pursue bringing COVID-19 vaccine to India after import relaxation"We remain committed to continuing our engagement with the government towards making the Pfizer and BioNTech vaccine available for use in t...
- Pfizer withdraws application for emergency use of its Covid vaccine in IndiaAccording to government sources, while Pfizer had sought clinical trial waiver for its vaccine, the SEC did not considered its proposal and...
- Pfizer is no longer seeking approval for emergency use of its COVID-19 vaccine in IndiaPfizer has decided to withdraw its application for Emergency Use Authorisation of its Covid-19 vaccine in India.
- COVID-19 vaccine pricing to help governments ensure minimal costs for people, says PfizerThe company also said governments globally are developing comprehensive and strategic pandemic response plans. At this time, it is most app...
- Pfizer starts talks with Covax facility for equitable distribution of COVID-19 vaccineThe company is in discussions with the Gavi vaccine alliance to potentially provide doses to the Covax facility, a Pfizer spokesperson told...
- Pfizer to stop manufacturing in its Chennai and Aurangabad facilitiesThe company however said that the exact timing of the exit of the sites is yet to be determined.
- Bad Medicine! Pfizer, Cipla, DRL, other 63 drug firms fail quality testAccording to the notification, 25 samples by Pfizer, nine each by Dr Reddy’s and Alembic, seven by Cipla and six by Zydus Healthcare were f...
- Dr Reddy's to contest Pfizer's patent suit over atorvastatinDrug maker Dr Reddy's Laboratories will contest the patent infringement case filed against it by the global pharmaceutical giant Pfizer ove...
- Pfizer may revise open offer price as stock gains 33%The success of Pfizer’s open offer for Pfizer India appears to be bleak, with the stock price of the Indian subsidiary quoting higher than ...
- Ranbaxy gets US patent office booster dose in Lipitor caseIn what would give a leg up to Ranbaxy, the US Patent and Trademark Office (USPTO) has rejected Pfizer’s appeal to re-issue patent for its ...
- Pfizer India evaluates impact of deal with J&JPfizer India, a subsidiary of the global pharmaceutical major Pfizer Inc, on Monday said it was evaluating the impact of the sale of global...
Load More
